TapewireFind a company

person · Reporting owner

Pearse Robert G.

Disclosed activity across 4 companies

Tapewire entity
39991
SEC CIK
0001580399

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
CROSSROADS SYSTEMS INCCRDS · Entity 172266DirectorJuly 10, 2017July 12, 2017
Enveric Biosciences, Inc.AMRH · Entity 8193DirectorFebruary 09, 2018February 13, 2018
NOVATION COMPANIES, INC.NOVC · Entity 13492DirectorAugust 23, 2017August 25, 2017
Star Equity Holdings, Inc.STRR · Entity 7343DirectorJune 05, 2026June 09, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

CROSSROADS SYSTEMS INC

Report date July 10, 2017 · Filed July 12, 2017

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect9,083 Reported balance After 2017-07-10 transaction · row 1
1 source row

Row 1 · 2017-07-10 · Grant · Acquired 3,465 · Balance 9,083

F1: Represents shares of restricted stock granted under the Issuer's 2010 Stock Incentive Plan, as amended, which shall vest on July 10, 2018.

Filing footnotes · ownership attribution and instrument terms

F1: Represents shares of restricted stock granted under the Issuer's 2010 Stock Incentive Plan, as amended, which shall vest on July 10, 2018.

Enveric Biosciences, Inc.

Report date February 09, 2018 · Filed February 13, 2018

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect40,473 Reported balance After 2018-02-09 transaction · row 1
1 source row

Row 1 · 2018-02-09 · Other · Acquired 8,710 · Balance 40,473

F1: Represents shares granted to the Reporting Person by the Issuer pursuant to the Issuer's 2015 Equity Incentive Award Plan in connection with the resolution of 2017 directors' fee payments owed by the Issuer to the Reporting Person.

Filing footnotes · ownership attribution and instrument terms

F1: Represents shares granted to the Reporting Person by the Issuer pursuant to the Issuer's 2015 Equity Incentive Award Plan in connection with the resolution of 2017 directors' fee payments owed by the Issuer to the Reporting Person.

NOVATION COMPANIES, INC.

Report date August 23, 2017 · Filed August 25, 2017

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect419,872 Reported balance After 2017-08-23 transaction · row 1
1 source row

Row 1 · 2017-08-23 · Grant · Acquired 208,333 · Balance 419,872

F1: Grant of restricted shares of common stock under the Novation Companies, Inc. 2015 Incentive Stock Plan in payment of a portion of the annual base compensation for each non-employee director. The number of restricted shares was calculated based on the closing price of the common stock on the grant date. The restricted shares will vest on August 23, 2018.

Filing footnotes · ownership attribution and instrument terms

F1: Grant of restricted shares of common stock under the Novation Companies, Inc. 2015 Incentive Stock Plan in payment of a portion of the annual base compensation for each non-employee director. The number of restricted shares was calculated based on the closing price of the common stock on the grant date. The restricted shares will vest on August 23, 2018.

Star Equity Holdings, Inc.

Report date June 05, 2026 · Filed June 09, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect29,218 Reported balance After 2026-06-05 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2026-06-05 · Purchase · Acquired 500 · Balance 29,218

F1: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $11.32 to $11.50 on June 5, 2026. The Reporting Person undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.

F2: Includes 12,516 Restricted Stock Units and 1,497 deferred shares credited to the Reporting Person's account under the Issuer's 2009 Incentive Stock and Awards Plan, as amended and restated. Each Restricted Stock Unit and deferred share represents the right to receive, at settlement, one share of common stock payable upon the first anniversary of the respective dates of grant of each award.

Filing footnotes · ownership attribution and instrument terms

F1: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $11.32 to $11.50 on June 5, 2026. The Reporting Person undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.

F2: Includes 12,516 Restricted Stock Units and 1,497 deferred shares credited to the Reporting Person's account under the Issuer's 2009 Incentive Stock and Awards Plan, as amended and restated. Each Restricted Stock Unit and deferred share represents the right to receive, at settlement, one share of common stock payable upon the first anniversary of the respective dates of grant of each award.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 05, 2026 Filed Jun 9, 2026 20:07 UTC Star Equity Holdings, Inc. STRR · Entity 7343 PurchaseCommon Stock 500 $11.46 $5,730.00
Disclosure

SEC source: 0001580399-26-000004 · wk-form4_1781035666.xml · nonDerivative · entry 1

Pearse Robert G. · CIK 0001580399 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,218

F1 · price: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $11.32 to $11.50 on June 5, 2026. The Reporting Person undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.

F2 · balance_after: Includes 12,516 Restricted Stock Units and 1,497 deferred shares credited to the Reporting Person's account under the Issuer's 2009 Incentive Stock and Awards Plan, as amended and restated. Each Restricted Stock Unit and deferred share represents the right to receive, at settlement, one share of common stock payable upon the first anniversary of the respective dates of grant of each award.

Read SEC document
May 27, 2026 Filed May 28, 2026 22:36 UTC Star Equity Holdings, Inc. STRR · Entity 7343 GrantCommon Stock 5,504 $0.00 $0.00
Disclosure

SEC source: 0001580399-26-000002 · wk-form4_1780007798.xml · nonDerivative · entry 1

Pearse Robert G. · CIK 0001580399 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,718

F1 · shares: Includes 5,504 Restricted Stock Units credited to the Reporting Person's account under the Issuer's 2009 Incentive Stock and Awards Plan, as amended and restated. Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock payable upon the first anniversary of the grant date. The number of Restricted Stock Units granted was determined using the closing price on May 27, 2026.

F2 · balance_after: Includes 12,516 Restricted Stock Units and 1,497 deferred shares credited to the Reporting Person's account under the Issuer's 2009 Incentive Stock and Awards Plan, as amended and restated. Each Restricted Stock Unit and deferred share represents the right to receive, at settlement, one share of common stock payable upon the first anniversary of the respective dates of grant of each award of Restricted Stock Units.

Read SEC document
September 09, 2025 Filed Sep 12, 2025 01:16 UTC Star Equity Holdings, Inc. STRR · Entity 7343 GrantCommon Stock 7,012 $0.00 $0.00
Disclosure

SEC source: 0001210708-25-000094 · wk-form4_1757639799.xml · nonDerivative · entry 1

Pearse Robert G. · CIK 0001580399 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,214

F1 · security: Includes 7,012 Restricted Stock Units credited to the Reporting Person's account under the Issuer's 2009 Incentive Stock and Awards Plan, as amended and restated. Each Restricted Stock Unit represents the right to receive, at settlement, one share of Common Stock payable upon the first anniversary of the Grant Date. The number of Restricted Stock Units granted was determined using the closing price on September 9, 2025.

F1 · shares: Includes 7,012 Restricted Stock Units credited to the Reporting Person's account under the Issuer's 2009 Incentive Stock and Awards Plan, as amended and restated. Each Restricted Stock Unit represents the right to receive, at settlement, one share of Common Stock payable upon the first anniversary of the Grant Date. The number of Restricted Stock Units granted was determined using the closing price on September 9, 2025.

Read SEC document
August 15, 2025 Filed Aug 19, 2025 00:11 UTC Star Equity Holdings, Inc. HSON · Entity 7343 GrantCommon Stock. 1,497 $0.00 $0.00
Disclosure

SEC source: 0001210708-25-000057 · wk-form4_1755562301.xml · nonDerivative · entry 1

Pearse Robert G. · CIK 0001580399 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,202

F1 · security: Share Units credited to the reporting person's account under the Hudson Global, Inc. (the "Company") Director Deferred Share Plan. Each Share Unit is the economic equivalent of one share of Common Stock. Share Units are payable only in Common Stock up to 90 days after a director's separation from service.

F1 · shares: Share Units credited to the reporting person's account under the Hudson Global, Inc. (the "Company") Director Deferred Share Plan. Each Share Unit is the economic equivalent of one share of Common Stock. Share Units are payable only in Common Stock up to 90 days after a director's separation from service.

Read SEC document
May 20, 2025 Filed May 22, 2025 20:38 UTC Star Equity Holdings, Inc. HSON · Entity 7343 GrantCommon Stock. 1,404 $0.00 $0.00
Disclosure

SEC source: 0001210708-25-000034 · wk-form4_1747946311.xml · nonDerivative · entry 1

Pearse Robert G. · CIK 0001580399 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,705

F1 · security: Share Units credited to the reporting person's account under the Hudson Global, Inc. (the "Company") Director Deferred Share Plan. Each Share Unit is the economic equivalent of one share of Common Stock. Share Units are payable only in Common Stock up to 90 days after a director's separation from service.

F1 · shares: Share Units credited to the reporting person's account under the Hudson Global, Inc. (the "Company") Director Deferred Share Plan. Each Share Unit is the economic equivalent of one share of Common Stock. Share Units are payable only in Common Stock up to 90 days after a director's separation from service.

Read SEC document
March 21, 2025 Filed Mar 24, 2025 20:18 UTC Star Equity Holdings, Inc. HSON · Entity 7343 GrantCommon Stock. 1,335 $0.00 $0.00
Disclosure

SEC source: 0001210708-25-000019 · wk-form4_1742847520.xml · nonDerivative · entry 1

Pearse Robert G. · CIK 0001580399 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,301

F1 · security: Share Units credited to the reporting person's account under the Hudson Global, Inc. (the "Company") Director Deferred Share Plan. Each Share Unit is the economic equivalent of one share of Common Stock. Share Units are payable only in Common Stock up to 90 days after a director's separation from service.

F1 · shares: Share Units credited to the reporting person's account under the Hudson Global, Inc. (the "Company") Director Deferred Share Plan. Each Share Unit is the economic equivalent of one share of Common Stock. Share Units are payable only in Common Stock up to 90 days after a director's separation from service.

Read SEC document
November 19, 2024 Filed Nov 21, 2024 21:04 UTC Star Equity Holdings, Inc. HSON · Entity 7343 GrantCommon Stock. 955 $0.00 $0.00
Disclosure

SEC source: 0001210708-24-000087 · wk-form4_1732223068.xml · nonDerivative · entry 1

Pearse Robert G. · CIK 0001580399 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,966

F1 · security: Share Units credited to the reporting person's account under the Hudson Global, Inc. (the "Company") Director Deferred Share Plan. Each Share Unit is the economic equivalent of one share of Common Stock. Share Units are payable only in Common Stock up to 90 days after a director's separation from service.

F1 · shares: Share Units credited to the reporting person's account under the Hudson Global, Inc. (the "Company") Director Deferred Share Plan. Each Share Unit is the economic equivalent of one share of Common Stock. Share Units are payable only in Common Stock up to 90 days after a director's separation from service.

Read SEC document
August 15, 2024 Filed Aug 16, 2024 20:02 UTC Star Equity Holdings, Inc. HSON · Entity 7343 GrantCommon Stock. 747 $0.00 $0.00
Disclosure

SEC source: 0001210708-24-000067 · wk-form4_1723838531.xml · nonDerivative · entry 1

Pearse Robert G. · CIK 0001580399 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,011

F1 · security: Share Units credited to the reporting person's account under the Hudson Global, Inc. (the "Company") Director Deferred Share Plan. Each Share Unit is the economic equivalent of one share of Common Stock. Share Units are payable only in Common Stock up to 90 days after a director's separation from service.

F1 · shares: Share Units credited to the reporting person's account under the Hudson Global, Inc. (the "Company") Director Deferred Share Plan. Each Share Unit is the economic equivalent of one share of Common Stock. Share Units are payable only in Common Stock up to 90 days after a director's separation from service.

Read SEC document
July 31, 2024 Filed Aug 2, 2024 20:36 UTC Star Equity Holdings, Inc. HSON · Entity 7343 GrantCommon Stock. 3,574 $0.00 $0.00
Disclosure

SEC source: 0001210708-24-000056 · wk-form4_1722631011.xml · nonDerivative · entry 1

Pearse Robert G. · CIK 0001580399 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,264

F1 · security: Share Units credited to the reporting person's account under the Hudson Global, Inc. (the "Company") Director Deferred Share Plan. Each Share Unit is the economic equivalent of one share of Common Stock. Share Units are payable only in Common Stock up to 90 days after a director's separation from service.

F1 · shares: Share Units credited to the reporting person's account under the Hudson Global, Inc. (the "Company") Director Deferred Share Plan. Each Share Unit is the economic equivalent of one share of Common Stock. Share Units are payable only in Common Stock up to 90 days after a director's separation from service.

Read SEC document
May 17, 2024 Filed May 21, 2024 20:06 UTC Star Equity Holdings, Inc. HSON · Entity 7343 GrantCommon Stock. 849 $0.00 $0.00
Disclosure

SEC source: 0001210708-24-000034 · wk-form4_1716321981.xml · nonDerivative · entry 1

Pearse Robert G. · CIK 0001580399 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,690

F1 · security: Share Units credited to the reporting person's account under the Hudson Global, Inc. (the "Company") Director Deferred Share Plan. Each Share Unit is the economic equivalent of one share of Common Stock. Share Units are payable only in Common Stock up to 90 days after a director's separation from service.

F1 · shares: Share Units credited to the reporting person's account under the Hudson Global, Inc. (the "Company") Director Deferred Share Plan. Each Share Unit is the economic equivalent of one share of Common Stock. Share Units are payable only in Common Stock up to 90 days after a director's separation from service.

Read SEC document
March 21, 2024 Filed Mar 22, 2024 20:06 UTC Star Equity Holdings, Inc. HSON · Entity 7343 GrantCommon Stock. 777 $0.00 $0.00
Disclosure

SEC source: 0001210708-24-000021 · wk-form4_1711137954.xml · nonDerivative · entry 1

Pearse Robert G. · CIK 0001580399 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,841

F1 · security: Share Units credited to the reporting person's account under the Hudson Global, Inc. (the "Company") Director Deferred Share Plan. Each Share Unit is the economic equivalent of one share of Common Stock. Share Units are payable only in Common Stock up to 90 days after a director's separation from service.

F1 · shares: Share Units credited to the reporting person's account under the Hudson Global, Inc. (the "Company") Director Deferred Share Plan. Each Share Unit is the economic equivalent of one share of Common Stock. Share Units are payable only in Common Stock up to 90 days after a director's separation from service.

Read SEC document
November 16, 2023 Filed Nov 20, 2023 21:33 UTC Star Equity Holdings, Inc. HSON · Entity 7343 GrantCommon Stock. 870 $0.00 $0.00
Disclosure

SEC source: 0001210708-23-000128 · wk-form4_1700515982.xml · nonDerivative · entry 1

Pearse Robert G. · CIK 0001580399 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,064

F1 · security: Share Units credited to the reporting person's account under the Hudson Global, Inc. (the "Company") Director Deferred Share Plan. Each Share Unit is the economic equivalent of one share of Common Stock. Share Units are payable only in Common Stock up to 90 days after a director's separation from service.

F1 · shares: Share Units credited to the reporting person's account under the Hudson Global, Inc. (the "Company") Director Deferred Share Plan. Each Share Unit is the economic equivalent of one share of Common Stock. Share Units are payable only in Common Stock up to 90 days after a director's separation from service.

Read SEC document
November 02, 2023 Filed Nov 13, 2023 23:30 UTC Star Equity Holdings, Inc. HSON · Entity 7343 GrantCommon Stock. 4,194 $0.00 $0.00
Disclosure

SEC source: 0001210708-23-000114 · wk-form4_1699918239.xml · nonDerivative · entry 1

Pearse Robert G. · CIK 0001580399 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,194

F1 · shares: Share Units credited to the reporting person's account under the Hudson Global, Inc. (the "Company") Director Deferred Share Plan. Each Share Unit is the economic equivalent of one share of Common Stock. Share Units are payable only in Common Stock up to 90 days after a director's separation from service.

Read SEC document
February 09, 2018 Filed Feb 13, 2018 01:09 UTC Enveric Biosciences, Inc. AMRH · Entity 8193 OtherCommon Stock 8,710 Not disclosed Not disclosed
Disclosure

SEC source: 0000921895-18-000527 · form410211002pea_02122018.xml · nonDerivative · entry 1

Pearse Robert G. · CIK 0001580399 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,473

F1 · kind: Represents shares granted to the Reporting Person by the Issuer pursuant to the Issuer's 2015 Equity Incentive Award Plan in connection with the resolution of 2017 directors' fee payments owed by the Issuer to the Reporting Person.

F1 · price: Represents shares granted to the Reporting Person by the Issuer pursuant to the Issuer's 2015 Equity Incentive Award Plan in connection with the resolution of 2017 directors' fee payments owed by the Issuer to the Reporting Person.

Read SEC document
January 01, 2018 Filed Jan 3, 2018 21:45 UTC Enveric Biosciences, Inc. AMRH · Entity 8193 Exercise / conversionRestricted Stock Unit · Derivative 9,063 $0.00 $0.00
Disclosure

SEC source: 0000921895-18-000049 · form410211002pea_01032018.xml · derivative · entry 2

Pearse Robert G. · CIK 0001580399 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,063 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: As previously disclosed in filings with the Securities and Exchange Commission, represents stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. On January 1, 2018, the RSUs vested in full based on the terms of a Restricted Stock Unit Agreement between the Issuer and the Reporting Person.

F1 · derivative.exercise_price: As previously disclosed in filings with the Securities and Exchange Commission, represents stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. On January 1, 2018, the RSUs vested in full based on the terms of a Restricted Stock Unit Agreement between the Issuer and the Reporting Person.

F1 · derivative.exercise_date: As previously disclosed in filings with the Securities and Exchange Commission, represents stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. On January 1, 2018, the RSUs vested in full based on the terms of a Restricted Stock Unit Agreement between the Issuer and the Reporting Person.

F1 · derivative.expiration_date: As previously disclosed in filings with the Securities and Exchange Commission, represents stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. On January 1, 2018, the RSUs vested in full based on the terms of a Restricted Stock Unit Agreement between the Issuer and the Reporting Person.

Read SEC document
January 01, 2018 Filed Jan 3, 2018 21:45 UTC Enveric Biosciences, Inc. AMRH · Entity 8193 Exercise / conversionCommon Stock 9,063 Not disclosed Not disclosed
Disclosure

SEC source: 0000921895-18-000049 · form410211002pea_01032018.xml · nonDerivative · entry 1

Pearse Robert G. · CIK 0001580399 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,763

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: As previously disclosed in filings with the Securities and Exchange Commission, represents stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. On January 1, 2018, the RSUs vested in full based on the terms of a Restricted Stock Unit Agreement between the Issuer and the Reporting Person.

Read SEC document
August 23, 2017 Filed Aug 25, 2017 18:46 UTC NOVATION COMPANIES, INC. NOVC · Entity 13492 GrantCommon Stock 208,333 $0.00 $0.00
Disclosure

SEC source: 0000921895-17-002235 · form411464pea_08252017.xml · nonDerivative · entry 1

Pearse Robert G. · CIK 0001580399 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 419,872

F1 · shares: Grant of restricted shares of common stock under the Novation Companies, Inc. 2015 Incentive Stock Plan in payment of a portion of the annual base compensation for each non-employee director. The number of restricted shares was calculated based on the closing price of the common stock on the grant date. The restricted shares will vest on August 23, 2018.

Read SEC document
July 10, 2017 Filed Jul 12, 2017 17:16 UTC CROSSROADS SYSTEMS INC CRDS · Entity 172266 GrantCommon Stock 3,465 $0.00 $0.00
Disclosure

SEC source: 0001144204-17-036583 · v470706_4.xml · nonDerivative · entry 1

Pearse Robert G. · CIK 0001580399 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,083

F1 · shares: Represents shares of restricted stock granted under the Issuer's 2010 Stock Incentive Plan, as amended, which shall vest on July 10, 2018.

Read SEC document
May 19, 2017 Filed May 23, 2017 22:26 UTC Enveric Biosciences, Inc. AMRH · Entity 8193 Exercise / conversionRestricted Stock Unit · Derivative 5,891 $0.00 $0.00
Disclosure

SEC source: 0000921895-17-001623 · form410211002e_05232017.xml · derivative · entry 2

Pearse Robert G. · CIK 0001580399 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,891 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: As previously disclosed in filings with the Securities and Exchange Commission, represents stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. The RSUs vested in full based on the terms of a Restricted Stock Unit Agreement between the Issuer and the Reporting Person.

F2 · security: On May 19, 2017, 5,891 shares of the Issuer's common stock were issued in settlement of the RSUs described in footnote (1) above.

F1 · derivative.exercise_price: As previously disclosed in filings with the Securities and Exchange Commission, represents stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. The RSUs vested in full based on the terms of a Restricted Stock Unit Agreement between the Issuer and the Reporting Person.

F2 · derivative.exercise_price: On May 19, 2017, 5,891 shares of the Issuer's common stock were issued in settlement of the RSUs described in footnote (1) above.

F1 · derivative.exercise_date: As previously disclosed in filings with the Securities and Exchange Commission, represents stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. The RSUs vested in full based on the terms of a Restricted Stock Unit Agreement between the Issuer and the Reporting Person.

F2 · derivative.exercise_date: On May 19, 2017, 5,891 shares of the Issuer's common stock were issued in settlement of the RSUs described in footnote (1) above.

F1 · derivative.expiration_date: As previously disclosed in filings with the Securities and Exchange Commission, represents stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. The RSUs vested in full based on the terms of a Restricted Stock Unit Agreement between the Issuer and the Reporting Person.

F2 · derivative.expiration_date: On May 19, 2017, 5,891 shares of the Issuer's common stock were issued in settlement of the RSUs described in footnote (1) above.

Read SEC document
May 19, 2017 Filed May 23, 2017 22:26 UTC Enveric Biosciences, Inc. AMRH · Entity 8193 Exercise / conversionCommon Stock 5,891 Not disclosed Not disclosed
Disclosure

SEC source: 0000921895-17-001623 · form410211002e_05232017.xml · nonDerivative · entry 1

Pearse Robert G. · CIK 0001580399 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,700

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: As previously disclosed in filings with the Securities and Exchange Commission, represents stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. The RSUs vested in full based on the terms of a Restricted Stock Unit Agreement between the Issuer and the Reporting Person.

F2 · price: On May 19, 2017, 5,891 shares of the Issuer's common stock were issued in settlement of the RSUs described in footnote (1) above.

F3 · balance_after: The Form 4 filed for the Reporting Person on May 3, 2017, incorrectly reported the amounts 52,872 and 49,700 in rows 1 and 2 of Column 5 of Table I. The correct numbers should have been 25,872 and 22,700, respectively.

Read SEC document
May 01, 2017 Filed May 3, 2017 22:18 UTC Enveric Biosciences, Inc. AMRH · Entity 8193 Exercise / conversionRestricted Stock Unit · Derivative 9,063 $0.00 $0.00
Disclosure

SEC source: 0000921895-17-001275 · form410211002e_05032017.xml · derivative · entry 3

Pearse Robert G. · CIK 0001580399 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,063 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents restricted stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. The RSUs vested in full on May 1, 2017, based on the terms of a RSU Agreement between the Issuer and the Reporting Person.

F1 · derivative.exercise_price: Represents restricted stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. The RSUs vested in full on May 1, 2017, based on the terms of a RSU Agreement between the Issuer and the Reporting Person.

F1 · derivative.exercise_date: Represents restricted stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. The RSUs vested in full on May 1, 2017, based on the terms of a RSU Agreement between the Issuer and the Reporting Person.

F1 · derivative.expiration_date: Represents restricted stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. The RSUs vested in full on May 1, 2017, based on the terms of a RSU Agreement between the Issuer and the Reporting Person.

Read SEC document
May 01, 2017 Filed May 3, 2017 22:18 UTC Enveric Biosciences, Inc. AMRH · Entity 8193 Tax withholdingCommon Stock 3,172 $6.59 $20,903.48
Disclosure

SEC source: 0000921895-17-001275 · form410211002e_05032017.xml · nonDerivative · entry 2

Pearse Robert G. · CIK 0001580399 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,700

F2 · shares: Represents number of shares withheld by the Issuer for the payment of taxes. No shares of Common Stock were sold by the Reporting Person in connection with this transaction. The Reporting Person will retain the net number of shares issued upon the settlement of the RSUs.

F3 · price: Closing market price of the Issuer's common stock on the transaction date.

Read SEC document
May 01, 2017 Filed May 3, 2017 22:18 UTC Enveric Biosciences, Inc. AMRH · Entity 8193 Exercise / conversionCommon Stock 9,063 Not disclosed Not disclosed
Disclosure

SEC source: 0000921895-17-001275 · form410211002e_05032017.xml · nonDerivative · entry 1

Pearse Robert G. · CIK 0001580399 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,872

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents restricted stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. The RSUs vested in full on May 1, 2017, based on the terms of a RSU Agreement between the Issuer and the Reporting Person.

Read SEC document
April 11, 2017 Filed Apr 14, 2017 20:35 UTC Enveric Biosciences, Inc. AMRH · Entity 8193 GrantRestricted Stock Unit · Derivative 9,063 $0.00 $0.00
Disclosure

SEC source: 0000921895-17-001063 · form410211002f_04142017.xml · derivative · entry 3

Pearse Robert G. · CIK 0001580399 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,063

Underlying: Common Stock · 9,063 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock.

F3 · derivative.exercise_date: These Restricted Stock Units are scheduled to vest on January 1, 2018.

F3 · derivative.expiration_date: These Restricted Stock Units are scheduled to vest on January 1, 2018.

Read SEC document
April 11, 2017 Filed Apr 14, 2017 20:35 UTC Enveric Biosciences, Inc. AMRH · Entity 8193 GrantRestricted Stock Unit · Derivative 9,063 $0.00 $0.00
Disclosure

SEC source: 0000921895-17-001063 · form410211002f_04142017.xml · derivative · entry 2

Pearse Robert G. · CIK 0001580399 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,063

Underlying: Common Stock · 9,063 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock.

F2 · derivative.exercise_date: These Restricted Stock Units are scheduled to vest on May 1, 2017.

F2 · derivative.expiration_date: These Restricted Stock Units are scheduled to vest on May 1, 2017.

Read SEC document
March 31, 2017 Filed Apr 4, 2017 17:32 UTC CROSSROADS SYSTEMS INC CRDS · Entity 172266 GrantCommon Stock 2,216 $0.00 $0.00
Disclosure

SEC source: 0001144204-17-018939 · v463563_4.xml · nonDerivative · entry 1

Pearse Robert G. · CIK 0001580399 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,618

F1 · shares: Represents shares of restricted stock granted under the Issuer's 2010 Stock Incentive Plan, as amended, which shall vest on March 31, 2018.

Read SEC document
January 24, 2017 Filed Jan 26, 2017 21:26 UTC Enveric Biosciences, Inc. AMRH · Entity 8193 Exercise / conversionRestricted Stock Unit · Derivative 16,809 $0.00 $0.00
Disclosure

SEC source: 0000921895-17-000106 · form410211002c_01262017.xml · derivative · entry 2

Pearse Robert G. · CIK 0001580399 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 16,809 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: As previously disclosed in filings with the Securities and Exchange Commission, represents stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. The RSUs vested in full based on the terms of a Restricted Stock Unit Agreement between the Issuer and the Reporting Person.

F2 · security: On January 24, 2017, 16,809 shares of the Issuer's common stock were issued in settlement of the RSUs described in footnote (1) above.

F1 · derivative.exercise_price: As previously disclosed in filings with the Securities and Exchange Commission, represents stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. The RSUs vested in full based on the terms of a Restricted Stock Unit Agreement between the Issuer and the Reporting Person.

F2 · derivative.exercise_price: On January 24, 2017, 16,809 shares of the Issuer's common stock were issued in settlement of the RSUs described in footnote (1) above.

F1 · derivative.exercise_date: As previously disclosed in filings with the Securities and Exchange Commission, represents stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. The RSUs vested in full based on the terms of a Restricted Stock Unit Agreement between the Issuer and the Reporting Person.

F2 · derivative.exercise_date: On January 24, 2017, 16,809 shares of the Issuer's common stock were issued in settlement of the RSUs described in footnote (1) above.

F1 · derivative.expiration_date: As previously disclosed in filings with the Securities and Exchange Commission, represents stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. The RSUs vested in full based on the terms of a Restricted Stock Unit Agreement between the Issuer and the Reporting Person.

F2 · derivative.expiration_date: On January 24, 2017, 16,809 shares of the Issuer's common stock were issued in settlement of the RSUs described in footnote (1) above.

Read SEC document
January 24, 2017 Filed Jan 26, 2017 21:26 UTC Enveric Biosciences, Inc. AMRH · Entity 8193 Exercise / conversionCommon Stock 16,809 Not disclosed Not disclosed
Disclosure

SEC source: 0000921895-17-000106 · form410211002c_01262017.xml · nonDerivative · entry 1

Pearse Robert G. · CIK 0001580399 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,809

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: As previously disclosed in filings with the Securities and Exchange Commission, represents stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. The RSUs vested in full based on the terms of a Restricted Stock Unit Agreement between the Issuer and the Reporting Person.

F2 · price: On January 24, 2017, 16,809 shares of the Issuer's common stock were issued in settlement of the RSUs described in footnote (1) above.

Read SEC document
January 04, 2017 Filed Jan 6, 2017 16:02 UTC CROSSROADS SYSTEMS INC CRDS · Entity 172266 GrantCommon Stock 1,437 $0.00 $0.00
Disclosure

SEC source: 0001144204-17-001083 · v456447_4.xml · nonDerivative · entry 1

Pearse Robert G. · CIK 0001580399 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,402

F1 · shares: Represents shares of restricted stock granted under the Issuer's 2010 Stock Incentive Plan, as amended, which shall vest on January 4, 2018.

Read SEC document
October 18, 2016 Filed Oct 20, 2016 21:15 UTC CROSSROADS SYSTEMS INC CRDS · Entity 172266 GrantCommon Stock 1,460 $0.00 $0.00
Disclosure

SEC source: 0001144204-16-128830 · v450872_4.xml · nonDerivative · entry 1

Pearse Robert G. · CIK 0001580399 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,965

F1 · shares: Represents shares of restricted stock granted under the Issuer's 2010 Stock Incentive Plan, as amended, which shall vest on October 18, 2017.

F2 · balance_after: On June 20, 2016, the Issuer effected a 1-for-20 reverse stock split of its Common Stock, resulting in adjustments to the Reporting Person's ownership.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.